Related Experiment Video
Updated: Jun 12, 2026
07:22
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
YKL-40 concentrations are not elevated in gestational diabetes.
Georg Schaller1, Johanna Maria Brix, Gudrun Placher-Sorko
1Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria. georg.schaller@wienkav.at
European Journal of Clinical Investigation
|May 22, 2010
Summary
This study found no difference in the inflammatory marker YKL-40 between women with gestational diabetes (GDM) and healthy controls. This suggests inflammation may not play a significant role in GDM, unlike in type 2 diabetes.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Immunology
Background:
- Gestational diabetes (GDM) is a growing pregnancy complication with unclear inflammatory mechanisms.
- YKL-40, a novel inflammatory marker, is linked to type 2 diabetes.
- This study is the first to explore YKL-40's role in GDM.
Purpose of the Study:
- To investigate the association between YKL-40 levels and gestational diabetes.
- To compare YKL-40 levels in GDM patients versus healthy pregnant controls.
Main Methods:
- 58 subjects (28 GDM, 30 controls) were assessed.
- Standard GDM risk factors were evaluated.
- YKL-40 levels were measured via oral glucose tolerance test (oGTT) during pregnancy and postpartum.
Main Results:
- No significant difference in YKL-40 levels was observed between GDM and control groups, during or after pregnancy.
- YKL-40 levels correlated with insulin, HOMA, and BMI.
- GDM patients exhibited higher fasting insulin, glucose levels, HbA1c, HOMA, and BMI compared to controls.
Conclusions:
- The lack of difference in YKL-40 suggests similar inflammatory status between GDM and control groups.
- The transient nature of GDM metabolic changes may explain the absence of YKL-40 differences, contrasting with type 2 diabetes findings.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...